TP53 and lung carcinoma: For lung cancer, allelic frequencies of TP53 mutations in cfDNA have very wide ranges, from 0.12% to 84.8% [29], suggesting they might either have originated early during the carcinogenic process (in patients with greater VAFs) or much later, even in disseminating CTCs (in patients with lower VAFs).